Exploration of novel heterofused 1,2,4-triazine derivative in colorectal cancer-Reference-Cited by-同舟云学术

Exploration of novel heterofused 1,2,4-triazine derivative in colorectal cancer

Published:2021-01-01 Issue:1 Volume:36 Page:535-548
ISSN:1475-6366
Container-title:Journal of Enzyme Inhibition and Medicinal Chemistry
language:en
Short-container-title:Journal of Enzyme Inhibition and Medicinal Chemistry

Author:

Hermanowicz Justyna Magdalena¹²,Szymanowska Anna³,Sieklucka Beata¹,Czarnomysy Robert⁴,Pawlak Krystyna⁵,Bielawska Anna³,Bielawski Krzysztof⁴,Kalafut Joanna⁶,Przybyszewska Alicja⁶,Surazynski Arkadiusz⁷,Rivero-Muller Adolfo⁶,Mojzych Mariusz⁸,Pawlak Dariusz¹⁹

Affiliation:

1. Department of Pharmacodynamics, Medical University of Bialystok, Bialystok, Poland

2. Department of Clinical Pharmacy, Medical University of Bialystok, Bialystok, Poland

3. Department of Biotechnology, Medical University of Bialystok, Bialystok, Poland

4. Department of Synthesis and Technology of Drugs, Medical University of Bialystok, Bialystok, Poland

5. Department of Monitored Pharmacotherapy, Medical University of Bialystok, Bialystok, Poland

6. Department of Biochemistry and Molecular Biology, Medical University of Lublin, Lublin, Poland

7. Department of Medicinal Chemistry, Medical University of Bialystok, Bialystok, Poland

8. Department of Chemistry, Siedlce University of Natural Sciences and Humanities, Siedlce, Poland

9. Department of Pharmacology and Toxicology, Faculty of Medicine, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland

Funder

National Science Center, Poland

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14756366.2021.1879803

Reference53 articles.

1. 2020. Available from: https://www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html [last accessed 14 Feb 2020].

2. Time Trend Analysis of Primary Tumor Resection for Stage IV Colorectal Cancer

3. Molecular Immunotherapy: Promising Approach to Treat Metastatic Colorectal Cancer by Targeting Resistant Cancer Cells or Cancer Stem Cells

4. Immunotherapy efficacy on mismatch repair-deficient colorectal cancer: From bench to bedside

5. An overview on the recent developments of 1,2,4-triazine derivatives as anticancer compounds

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis and Anti‐Cancer Evaluation of Quinoline‐1,2,4‐triazine Hybrids;ChemistrySelect;2024-08-28

2. The activity of pyrazolo[4,3- e ][1,2,4]triazine and pyrazolo[4,3- e ]tetrazolo[1,5- b ][1,2,4]triazine sulphonamide derivatives in monolayer and spheroid breast cancer cell cultures;Journal of Enzyme Inhibition and Medicinal Chemistry;2024-05-03

3. Novel synthesis of new triazine sulfonamides with antitumor, anti-microbial and anti-SARS-CoV-2 activities;BMC Chemistry;2024-03-26

4. Exploring the in vivo anti-cancer potential of Neosetophomone B in leukemic cells using a zebrafish xenograft model;Experimental Cell Research;2024-02

5. Zebrafish xenograft as a tool for the study of colorectal cancer: a review;Cell Death & Disease;2024-01-09